Statement of Retraction: Hospitalization-related costs associated with oral agents targeting the prostacyclin pathway for pulmonary arterial hypertension

"Statement of Retraction: Hospitalization-related costs associated with oral agents targeting the prostacyclin pathway for pulmonary arterial hypertension." Journal of Medical Economics, 27(1), p. 626

This article refers to:

RETRACTED ARTICLE: Hospitalization-related costs associated with oral agents targeting the prostacyclin pathway for pulmonary arterial hypertension